Main Article

A new report commissioned by the Centers for Disease Control and Prevention (CDC) profiles the U.S. lab market, as well as calls for changes to the Medicare payment system, concluding that the system needs to be redesigned in line with growing scientific, economic, and business challenges. The report, Laboratory Medicine: A National Status Report, also calls the current fee schedule method out-of-date, bearing no relationship to current production costs, particularly relating to molecular diagnostics and other genetic-testing methodologies.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

July 2008 - Table of Contents

LIR July 2008 (full PDF issue)

Survey Finds Outreach Labs Growing at 4 Times the Rate of National Labs

Valuations Close to All-Time High; Labs Continue to Attract Private Equity Interest

Former Quest Execs Acquire New Jersey-Based Genatom and Launch Manhattan Lab

Breaking Legislative Update: House Passes Medicare Bill Repeal Competitive Bidding, Physician Fee Fix

Spectrum Labs Implements Phlebotomist Payment Collection Program

Have Rock Solid Business Infrastructure, Will Grow Pathology Business

CDC Report Assesses Lab Market, Calls for Medicare Changes

Rosetta Genomics Buys Parkway Clinical Labs for $3 Million+

Post IPO, Genoptix’s Focus Is on Growing Volume and Expanding Sales Operations

Lab Stocks Inch Upward in June, but Down 4% So Far in 2008

Sonic Healthcare to Acquire Two German Labs for Over $130 Million